Tocotrienol-rich fractions (TRF) supplementation in school-going children with Attention Deficit/Hyperactive Disorder (ADHD): A randomized controlled trial

BMC Nutrition

Volumn 2, Issue 1, 2016, Pages

  Tan, May Loong ^a   Foong, Siew Cheng ^a   Foong, Wai Cheng ^a   Yusuff, Yusni ^b   Chettiar, Saralla M ^a  

^a PENANG MEDICAL COLLEGE   (Malaysia)

^b Hospital Sultan Abdul Halim   (Malaysia)

Author keywords

ADHD; Antioxidant; Children; Supplements; Tocotrienol rich fractions; Tocotrienols

Indexed keywords

EID: 84993969897     PISSN: None     EISSN: 20550928     Source Type: Journal    
DOI: 10.1186/s40795-016-0055-9     Document Type: Article

References (35)

1. Subcommittee on Attention-Deficit/Hyperactive Disorder, Steering Committee on quality improvement and management. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactive Disorder in Children and Adolescents. Pediatrics. 2011;128(5):1007-22.
2. Brown RT, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics. 2001;107(3):E43.
3. Hoagwood K, et al. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry. 2000;39(2):198-206.
4. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559-67.
5. Storebo OJ, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2015;11:CD009885.
6. Charach A, et al. Using stimulant medication for children with ADHD: what do parents say? A brief report. J Can Acad Child Adolesc Psychiatry. 2006;15(2):75-83.
7. Telford C, et al. Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder. Soc Psychiatry Psychiatr Epidemiol. 2013;48(2):337-44.
8. Weber W, Newmark S. Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin North Am. 2007;54(6):983-1006. xii.
9. Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med. 2007;28(5-6):692-728.
10. Serbinova EA, Packer L. Antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Methods Enzymol. 1994;234:354-66.
11. Ng F, et al. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851-76.
12. Joseph N, et al. Oxidative Stress and ADHD: A Meta-Analysis. J Atten Disord. 2015;19(11):915-24.
13. Trebaticka J, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Eur Child Adolesc Psychiatry. 2006;15(6):329-35.
14. Katz M, et al. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial. J Atten Disord. 2010;14(3):281-91.
15. Zhou R, Han X, Wang J, Sun J. Baicalin may have a therapeutic effect in attention deficit hyperactivity disorder. Medical hypotheses. 2015;85(6):761-4.
16. Khanna S, et al. Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection. J Neurochem. 2010;112(5):1249-60.
17. Stevens LJ, et al. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav. 1996;59(4-5):915-20.
18. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM IV-TR). 2000, Arlington: American Psychiatric Association
19. NICHQ. Caring for Children with ADHD: A Resource Toolkit for Clinicians (1st Edition). 2002; http://www.nichq.org/childrens-health/adhd/resources/adhd-toolkit. Accessed 17 April 2012.
20. Bard DEP, et al. The Psychometric Properties of the Vanderbilt Attention-Deficit Hyperactivity Disorder Diagnostic Parent Rating Scale in a Community Population. Journal of Developmental & Behavioral Pediatrics. 2013;34(2):72-82.
21. Wolraich MLMD, et al. The Psychometric Properties of the Vanderbilt Attention-Deficit Hyperactivity Disorder Diagnostic Teacher Rating Scale in a Community Population. Journal of Developmental & Behavioral Pediatrics. 2013;34(2):83-93.
22. Md Nasir N, Mohd Shahidi R, Ab Rahman A, Othman A. A Preliminary Study on the Reliability of the Malay Version of the National Initiative for Children's Healthcare Quality (NICHQ) Vanderbilt Assessment Scale: Parent and Teacher Informant among School Children in Kelantan, Malaysia, Poster presentation, 6th National Pediatrics Research Conference Universiti Sains Malaysia. 2013
23. Yap SP, et al. Simple high-performance liquid chromatographic method for the determination of tocotrienols in human plasma. J Chromatogr B Biomed Sci Appl. 1999;735(2):279-83.
24. Sinn N, Bryan J. Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD. J Dev Behav Pediatr. 2007;28(2):82-91.
25. Dupont W, Plummer W. Power and sample size calculations: A review and computer program. Controlled Clinical Trials. 1990;11:116-28.
26. IBM Corp. IBM SPSS Statistics for Windows, Version 22.0. Armonk: IBM Corp; 2013.
27. StataCorp. Stata Statistical Software: Release 12. College Station: StataCorp LP; 2011.
28. Yap SP, Yuen KH, Wong JW. Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol. 2001;53(1):67-71.
29. Beoy LA, Woei WJ, Hay YK. Effects of tocotrienol supplementation on hair growth in human volunteers. Trop Life Sci Res. 2010;21(2):91-9.
30. Nesaretnam K et al. Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: a pilot clinical trial. Breast Cancer Research. 2010;12(5):R81.
31. Arnold LE. Placebo response and the company it keeps. JAMA Pediatr. 2013;167(11):1000-1.
32. Perera H, et al. Combined ?3 and ?6 Supplementation in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Refractory to Methylphenidate Treatment. J Child Neurol. 2012;27(6):747-53.
33. Xiao ZH, et al. Diagnostic value of Vanderbilt ADHD Parent Rating Scale in attention deficit hyperactivity disorder. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(5):348-52.
34. Liston C, et al. Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point? Biol Psychiatry. 2011;69(12):1168-77.
35. Kitajima H, et al. Long-term alpha-tocopherol supplements may improve mental development in extremely low birthweight infants. Acta Paediatr. 2015;104(2):e82-9.